Antidepressants ‘substantially increase risk’ of low blood pressure when standing up in older people, study results suggest Researchers found that patients aged over 60 years who were prescribed selective serotonin re-uptake inhibitors were at a four-fold increased risk of postural hypotension in first four weeks of use.…
Lost days: the unstemmed rise in mental health-related absences There has been a significant rise in sickness absence for mental health reasons among hospital pharmacists in England over the past five years. What needs to change and where can NHS pharmacists access help in the meantime?…
MHRA to review blood monitoring requirements for clozapine patients Starting in summer 2025, the Medicines and Healthcare products Regulatory Agency will seek views on ways to improve awareness of patient risks related to clozapine.…
Coroner writes to ICB following death of patient who took too many of their prescribed drugs The ‘Prevention of future deaths’ report, published on 16 April 2025, was issued following the death of patient who was waiting for mental health support.…
Stimulant and non-stimulant agents for ADHD This medication guide details the different types of treatments for attention deficit hyperactivity disorder, for both adults and children.…
Antidepressants added to PCN structured medication review list From 2025/2026, primary care networks are required to include people using antidepressants for structured medication reviews as part of medicines optimisation processes for “high-risk cohorts”.…
More than half of pharmacy staff struggle with mental health over medicines shortages, reveals survey Respondents to the Royal Pharmaceutical Society Workforce Wellbeing Survey also cited inadequate staffing, lack of work–life balance and increased financial pressures as factors that negatively impact their mental health.…
Antidepressant use associated with increased hospitalisation in treatment of bipolar disorder, research suggests Of the specific monotherapies analysed, only lithium was associated with lower depression-related hospitalisation risk.…
The novel schizophrenia drug showing renewed potential for better outcomes A novel acetylcholine receptor drug has become the first new medicine to treat schizophrenia in decades. But even after gaining approval in the United States, experts are still conflicted on its benefits over current antipsychotic medicines.…
Recognition and management of delirium An overview of delirium, its symptoms and subtypes, including how to assess and diagnose, with an overview of non-pharmacological and pharmacological management.…
